Clinical pharmacokinetics of candesartan.
Gleiter CH, Mörike KE.
Clin Pharmacokinet · research support, non-u.s. gov't; review; journal article · DOI 10.2165/00003088-200241010-00002 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för O-desethyl candesartan. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
6 hitsDetermination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection.
Stenhoff H, Lagerström PO, Andersen C.
J Chromatogr B Biomed Sci Appl · journal article · DOI 10.1016/s0378-4347(99)00247-9Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis.
Pfister M, Schaedeli F, Frey FJ, Uehlinger DE.
Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1046/j.1365-2125.1999.00939.xPharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.
Hübner R, Högemann AM, Sunzel M, Riddell JG.
J Hum Hypertens · clinical trial; randomized controlled trial; journal articlePharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
de Zeeuw D, Remuzzi G, Kirch W.
J Hum Hypertens · journal articleDevelopment and validation of column-switching high-performance liquid chromatographic methods for the determination of a potent AII receptor antagonist, TCV-116, and its metabolites in human serum and urine.
Lee JW, Naidong W, Johnson T, Dzerk A, Miyabayashi T, Motohashi M.
J Chromatogr B Biomed Appl · clinical trial; journal article · DOI 10.1016/0378-4347(95)00146-8